Genascence

Palo Alto, United States

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases

$11.6M raised

Feb 2023

Grant

Top Investors

DeepWork Capital Pacira Pharmaceuticals California Institute for Regenerative Medicine University of Florida Research Foundation Polymerase Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Genascence

How much funding has Genascence raised?

Genascence has raised $11.6M in total funding. The most recent round was Grant. The last funding was announced in February 2023.

Who are Genascence's investors?

Genascence's investors include DeepWork Capital, Pacira Pharmaceuticals, California Institute for Regenerative Medicine, University of Florida Research Foundation, Polymerase Capital.

Where is Genascence headquartered?

Genascence is headquartered in Palo Alto, United States.

What does Genascence do?

Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases

What stage is Genascence at?

Genascence is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 23, 2023.

MLA

"Genascence — Funding & Investors." VCBacked, February 23, 2023, https://www.vcbacked.co/company/genascence. Accessed July 3, 2026.

APA

VCBacked. (2023). Genascence — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/genascence

Wikipedia (cite web)

{{cite web |title=Genascence — Funding & Investors |url=https://www.vcbacked.co/company/genascence |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 23, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K